Financhill
Back

Oncternal Therapeutics Vs. Theriva Biologics Industry Stock Comparison

Sell
36

ONCT
Oncternal Therapeutics

Last Price:
8.22
Seasonality Move:
-6.59%
Sell
27

TOVX
Theriva Biologics

Last Price:
0.35
Seasonality Move:
-6.11%
Sell
36
Oncternal Therapeutics (ONCT) is a Sell

Is Oncternal Therapeutics a Buy, Sell or Hold?

  • The current Oncternal Therapeutics [ONCT] share price is $8.18. The Score for ONCT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • ONCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Theriva Biologics (TOVX) is a Sell

Is Theriva Biologics a Buy, Sell or Hold?

  • The current Theriva Biologics [TOVX] share price is $0.36. The Score for TOVX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • TOVX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ONCT Stock Price Chart

What is Oncternal Therapeutics's stock price today?

  • The Oncternal Therapeutics share price today is $8.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ONCT is experiencing selling pressure, which indicates risk of future bearish movement.

TOVX Stock Price Chart

What is Theriva Biologics's stock price today?

  • The Theriva Biologics share price today is $0.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TOVX is experiencing slight selling pressure.

ONCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 43.23 Sell
Chaikin Money Flow: -2075 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.38 - 8.94) Sell
Bollinger Bands (100): (7.91 - 9.95) Sell

TOVX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 36.91 Sell
Chaikin Money Flow: -2378 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.4 - 0.44) Sell
Bollinger Bands (100): (0.41 - 0.51) Sell

ONCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.6 Sell
20-day SMA: 8.59 Sell
50-day SMA: 8.74 Sell
200-day SMA: 7.77 Buy
8-day EMA: 8.53 Sell
20-day EMA: 8.6 Sell
50-day EMA: 8.68 Sell
200-day EMA: 9.1 Sell

TOVX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.4 Sell
20-day SMA: 0.41 Sell
50-day SMA: 0.44 Sell
200-day SMA: 0.49 Sell
8-day EMA: 0.4 Sell
20-day EMA: 0.41 Sell
50-day EMA: 0.43 Sell
200-day EMA: 0.53 Sell

Oncternal Therapeutics Earnings Growth & ONCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.43 per share, and an increase next year of $3.53 per share.

Theriva Biologics Earnings Growth & TOVX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and an increase next year of $0.05 per share.

Oncternal Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Theriva Biologics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):